Trial Profile
A phase I/II randomized, double-blind, placebo-controlled pilot study of beta-D-2,6-diaminopurine dioxolane (DAPD) [amdoxovir] versus DAPD plus mycophenolate mofetil in treatment-experienced patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2021
Price :
$35
*
At a glance
- Drugs Amdoxovir (Primary) ; Mycophenolate mofetil (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- 24 Oct 2005 New trial record.